This result fits to the findings of Boldin et al. who reported a dysregulation of NF-κB signalling in miR-146a knockout-mice and of Bhaumik et al., who showed that miR-146a supresses NF-κB signalling in human breast cancer cells16, 40. This evidence concerns the gene NFKB1 and breast carcinoma.